Clinical utility and cost-effectiveness of a molecular biomarker for immune checkpoint inhibitor response monitoring and treatment decisions.

Authors: Zachary Rivers, Akash Mitra, Victoria L. Chiou, Halla Nimeiri, Sheetal Mehta Kircher, David D. Stenehjem, Rotem Ben-Shachar, Charu Aggarwal

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23338

Source: Full article

---

Abstract

e23338